Showing 641 - 660 results of 2,530 for search '"Vaccine"', query time: 0.06s Refine Results
  1. 641
  2. 642
  3. 643
  4. 644
  5. 645
  6. 646
  7. 647
  8. 648
  9. 649
  10. 650
  11. 651
  12. 652

    Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study by Moataz Alhaj

    Published 2016-01-01
    “…This review provides significant information about the prevention options of RVF along with the safety-efficacy profile of commercial vaccines and some of RVF vaccination strategies. Information presented in this paper was obtained through a systematic investigation of published data about RVF vaccines. …”
    Get full text
    Article
  13. 653
  14. 654

    COVID-19 Vaccine Acceptance among Ajman Undergraduate Dental Students: A Cross-Sectional Study by M. A. Jaber, M. Abdelmagied, E. M. El-Ameen, K. I. Afrashtehfar

    Published 2023-01-01
    “…This cross-sectional study aimed to identify factors associated with the willingness of dental medicine students to receive the COVID-19 vaccine. Objectives. The study sought to assess the knowledge, attitudes, and behaviors of undergraduate dental students toward COVID-19 vaccines and to identify determinants, motivators, and barriers to vaccine uptake and booster receipt. …”
    Get full text
    Article
  15. 655

    Saccharomyces Boulardii and Saccharomyces Cerevisiae Improve Immunity in Broilers Vaccinated Against Pasteurella Multocida and Salmonella Gallinarum by C Von Mühlen, NL Conrad, AP Roll, RC Dias, FPL Leite, CD Corcini, AS Varela Junior, VFB Roll

    Published 2025-02-01
    “…A total of 105 male Cobb 500 broilers were divided into four groups: T1 (vaccinated, no supplement, n = 30), T2 (vaccinated, S. boulardii supplement, n = 30), T3 (vaccinated, S. cerevisiae supplement, n = 30), and T4 (non-vaccinated, no supplement, n = 15). …”
    Get full text
    Article
  16. 656
  17. 657
  18. 658

    COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada: Protocol for a scoping review. by Peter A Newman, Luke Reid, Suchon Tepjan, Sophia Fantus, Kate Allan, Thabani Nyoni, Adrian Guta, Charmaine C Williams

    Published 2022-01-01
    “…<h4>Introduction</h4>Despite the development of safe and highly efficacious COVID-19 vaccines, extensive barriers to vaccine deployment and uptake threaten the effectiveness of vaccines in controlling the pandemic. …”
    Get full text
    Article
  19. 659
  20. 660